Předmět: |
|
Zdroj: |
Medical Devices & Surgical Technology Week; 2/18/2024, p689-689, 1p |
Abstrakt: |
A new report discusses research on left ventricular assist devices (LVADs) and their impact on patients with aortic valve regurgitation (AR). The study focuses on transcatheter aortic valve implantation (TAVI) as an alternative to surgical aortic valve replacement (SAVR) for patients with high surgical risk profiles. The research evaluates procedural outcomes and survival rates in LVAD patients who underwent TAVI, highlighting strategies to enhance device success. The study concludes that TAVI shows promising outcomes and early survival rates in LVAD patients with AR, and further research is needed to optimize outcomes in this patient population. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|